F11R and glioblastoma: The results show that hypomethylation of JAM-A can be observed in 18 types of cancers, among which low methylation levels were correlated with poor prognosis in multiple cancers including CESC, GBM, HNSC, KIRC, LGG, SARC, SKCM, and UVM.